ABSTRACT
Chroni c low back pain is a prevalent condition, resulting in expenditure of at least $13 billion a year for medical care in the United States. [1] [2] [3] Many approaches are available for managing this condition, including physical therapy, oral or injected medications, interventional spinal methods, surgery, or alternative therapy. Although spinal interventional methods and surgery have limited management roles in chronic pain, chronic use of medications, such as narcotics, have many side-effects.
Acupuncture is a low-risk treatment commonly used in the management of musculoskeletal pain, although systematic review has not established its effectiveness. 4 The National Institutes of Health consensus report on acupuncture states that acupuncture may be useful in such pain. 5 Considering the prevalence and economic impact of chronic low back pain, acupuncture's minimal toxicity warrants attempts to increase its therapeutic efficacy. It is suggested that these attempts be based on better scientific understanding of acupuncture's local mechanism or mechanisms of action because the central analgesic actions of acupuncture seem to be nonspecific. 6 As acupuncture is characterized by needle penetration or movement, hence its name, its local analgesic effect should be secondary to those actions, regardless of whether that effect is one of placebo or not.
Traditional acupuncture uses fine acupuncture needles at acupuncture points on meridians to relieve pain. Acupuncture points, muscle trigger points, and motor end-plate zones (MEPZs) may be identical. 7, 8 If so, relief of musculoskeletal pain by acupuncture would not be limited to classical acupuncture points on meridians. 7 Gunn 9 uses intramuscular stimulation to relieve myofascial pain by dry-needling muscles, with acupuncture needles, at tender motor points. This departure from classical acupuncture, regardless of consideration as a modification or different modality than acupuncture, allows stimulation of deeper motor points by using a manual plunger for insertion, oscillation, and twirling of acupuncture needles. We have shown that musculoskeletal pain relief can be achieved by additional changes to classical acupuncture and intramuscular stimulation methods. A monopolar needle, stronger and firmer than an acupuncture needle, is used for insertion into deep motor points, eliminating the use of a plunger. 10 -12 The basis of pain relief after electromyography (EMG) is that intramuscular needle movements lead to insertional activity and microtwitches. 11 Occasionally, acupuncture needle penetration or manipulation in classical or electrical acupuncture, intramuscular stimulation, and trigger-point localization also evoke small local twitches. These observations suggest that needle insertion or manipulation induces local muscle twitches, which may mediate musculoskeletal pain relief. 9, 13 We propose that significantly greater pain relief will occur with electrical twitch-obtaining intramuscular stimulation (ETOIMS) than dry needling of the same muscle or overlying skin. If pain relief is twitch mediated, because ETOIMS applies electricity through a monopolar EMG needle electrode to deep MEPZs, potentially more MEPZs may be stimulated to twitch. The design of this pilot crossover study is to minimize bias in determining the local site of analgesic action between needle stimulation of skin, needle stimulation of muscle without electricity, and needle stimulation of muscle with electricity and to affirm that muscle stimulation is a prerequisite for pain relief.
MATERIALS AND METHODS

Overview
The design involved two experimental groups, the muscle stimulation (MS) group, in which a monopolar EMG needle electrode was inserted into multiple sites in paraspinal muscles, and the ETOIMS group, in which a monopolar EMG needle electrode was inserted into the same muscles as in the MS group, during a different phase of the crossover design, and through which an electric current was supplied at individual points. The control group received skin stimulation (SS), in which insertion of an identical monopolar EMG needle electrode was limited to the skin (i.e., no penetration into muscle and no electricity). The skin stimulated in this group was situated directly over the muscles into which the experimental groups had their needle electrodes inserted (i.e., this was where the needle electrodes penetrated during different phases of the crossover design).
A total of 12 adult patients (six men and six women) with chronic, stable, low back pain of 3-60 mos in duration (mean, 28.2 Ϯ 19.1 mos) were admitted into the study. Patients' ranged in age from 33 to 77 yrs (mean, 53.4 Ϯ 13.9 yrs). Subjects had diffuse lower back pain with paraspinal spasm. Trigger-point searches were not performed. There were no localizing neurologic signs in any patient ( Table 1 shows the patient profile). Exclusion criteria included a history of pain extending below the buttock, drug or alcohol abuse, use of opioid-containing medication, change in character or severity of the pain within the previous 3 mos, presence of acute nerve root irritation (sciatica), previous spinal surgery, spinal nerve root or spinal cord compression, previous use of acupuncture, skin infections, open wounds, bleeding disorders (primary or drug induced), immune deficiency, valvular heart disease, pacemakers, pending medicolegal litigation, pending worker's compensation claim, inability to complete the visual analog scale (VAS), pregnancy (including if planned within the next 6 mos), or intent to move (i.e., potentially unavailable for follow-up). There was no discrimination regarding sex, race, or socioeconomic factors.
The institutional review board approved this controlled, singleblinded, crossover-design study. Before beginning the protocol, the patients recorded a VAS for pain twice a day for 1 wk. The order of treatment was unknown to the patients. Twelve patients received these modalities in the following sequence: MS, SS, and ETOIMS with a 2-wk washout period between the treatments. Two weeks of washout period is enough for patients with chronic pain because this is the clinical experience of the primary author. 5 The treatments were performed simultaneously without discussion of findings between personnel involved in the study.
The primary investigator trained two physiatrists within 1 day, one for performing the physical examination and the other for treatments. The trained physician, utilizing a similar technique, needled the low back for each group: MS, SS, or ETOIMS. A disposable 37-mm-long monopolar EMG needle was used for treatments. SS consisted of superficial needling of the skin, avoiding penetration of underlying fascia. MS resulted from inserting the entire length of the 37-mm-long monopolar needle, to the hub. The electrical source for ETO-IMS was from the Keypoint EMG machine (Medtronic Dantec, Copenhagen, Denmark) using the following stimulus variables: pulse duration of 0.5 msecs, frequency of 2 Hz, and a current strength of 2 mA. In ETO-IMS, after insertion of the 37-mmlong monopolar needle to individual points as in MS, a silent foot switch was pressed to stimulate these points. All patients completed the study, which lasted 6 wks.
General Research Procedure
A research assistant distributed and collected all study-related forms at the time of treatment, scheduled patient appointments, and followed through to obtain return of all studyrelated forms. The treating physician was not aware of the patients' pain levels throughout the study.
Patients received treatment in the following manner: the monopolar EMG needle electrode was inserted (along edges of intramuscular bands and muscular grooves from T10 to S1) and kept stationary for 2 secs, then withdrawn. All patients received identical numbers of needle penetrations for each of the three types of stimulation. Ten points were stimulated along the edges of intramuscular bands, along each of three vertical lines, separated by approximately 1 cm, starting lateral to the spinous process, for a total of 30 points on each side of the spine. The entire procedure lasted Ͻ20 mins. In the SS group, the needle was inserted into but not through the skin; in the MS and ETOIMS groups, the needle was inserted through the same skin area into underlying muscle to the same depth.
The crossover study occurred every 2 wks. Only the treating physician was aware of the sequence of the treatments, which were applied in the following order: (1) MS, (2) SS, and (3) ETOIMS. Patients were not asked questions concerning their symptoms by any of the personnel involved in the study. The patient, examining physician, research assistant, and the statistician remained blinded throughout the study.
Treatment Procedure
One Week Before Treatment. Each patient recorded a pain diary twice a day for 7 days before the first treatment session. He or she marked the pain level on a standard 10-cm VAS from a score of 0, equaling no pain, to a score of 10, equaling the worst pain. The patients were instructed not to change the type of pain medications used during the course of the study. When treatments began, each patient was instructed to report any unusual reactions to the treatments on the comment section of the pain diary ( Table 2) .
Day of Treatment.
The patient returned the previous week's pain diary on the day of treatment. The research assistant provided and collected from the patient a pretreatment pain level VAS sheet. The examining physiatrist performed the following examinations on the patient: spine flexion (distance in centimeters from the tip of the third digit to the floor on maximal forward flexion); flexion, abduction, external rotation, and extension testing (vertical distance in centimeters between the lateral end of the ipsilateral knee crease and the surface of the bed, with the ipsilateral heel on the contralateral knee cap); and a straight-leg raising test (in degrees) using a goniometer. None of the patients had straight-leg raising testing that caused radicular pain (Table 2) . With the patient standing and bearing weight on the test side, the following measurements were made: the ability to lift the heel off the floor by supporting weight on the forefoot (vertical distance in centimeters between the floor surface and plantar surface of the heel measured) and the ability to lift the toes off the floor by supporting weight on the heel (vertical distance in centimeters between the floor surface and the plantar surface of the metatarsophalangeal joint of the great toe measured). The patient was instructed to hold the examination table only for balance and to avoid using arm strength to perform these tests. Measurements included were those that can be easily performed, and the physiatrists involved in the experiment were already familiar with these techniques. Although their techniques were reassessed after training, formal repeatability tests were not done.
Immediately after treatment, the research assistant provided and collected from the patient the posttreatment pain level VAS sheet. The examining physiatrist who was blinded to the type of treatment the patient had received then performed the physical examination immediately after the treatment. Finally, the patient received a pain diary to be filled out twice daily for the next 2 wks and was instructed to return after 2 wks.
Data Analysis
The analysis of variance test was used with significance set at P Ͻ 0.05 for comparison of VAS levels, percentage of pain relief, and physical examination changes between groups immediately after treatment and for each of the 2 wks after treatments. The software used was by Statistica (Tulsa, Oklahoma).
RESULTS
Immediate, posttreatment, absolute VAS levels were reduced signifi- Table 3 ). The percentage of immediate improvement in physical tests was significant in one out of nine tests after MS (improvement in heel lift, P Ͻ 0.05) and ETOIMS (improvement in flexion, abduction, external rotation, and extension test, P Ͻ 0.05), but no significant changes occurred with any of the tests after SS. In the 2 wks after treatment, absolute VAS levels for ETOIMS were significantly lower than those for MS and SS (P Ͻ 0.05 for MS and P Ͻ 0.0001 for SS) ( Table 4 ). There was a tendency to have increased pain after SS treatment. ETOIMS treatment resulted in a greater percentage of pain relief in the first week after treatment, although this was not statistically significant from that of MS and SS (Fig.  1 ). Gunn 9 postulates that myofascial pain involves mechanical traction of muscle fibers shortened by denervation on pain-sensitive regions, such as bones, tendons, joints, nerves, and blood vessels. To desensitize and relax these muscle fibers, at tender motor points he mechanically inserts, twirls, and oscillates acupuncture needles. Potentially, these tender muscle motor points fit the clinical description of myofascial trigger points, although Gunn's definition of motor points 9 was not equivalent to the classical description of the motor point as being the most sensitive site to electrical stimulation. Monopolar EMG needle insertion at MEPZs or the nerve-muscle junction results in electrical activity identical to that noted at myofascial trigger points. 8, 11, 14 The elicitation of endplate spikes, grouped single-muscle fiber discharges, fasciculations, and myokymic discharges cause microtwitches. These discharges or microtwitches can cause immediate muscle fiber contraction and then relaxation, which may be the basis of pain relief with needling tender MEPZs. 11, 13, 14 Similarly, elicitation of microtwitches may be the basis of pain relief in methods in which needle manipulation and movement are integral elements, such as intramuscular stimulation and classical and electrical acupuncture. Muscle contraction and relaxation can be induced with ETOIMS and should produce more predictable musculoskeletal pain relief. This has been the clinical experience of the primary investigator. 12 The results from this study support the hypothesis that ETOIMS produces greater immediate pain relief than nonelectrical stimulation of muscle and significantly greater pain relief than nonelectrical stimulation of skin. If only dealing with a spinal cord pain gate mechanism, the superior analgesia of muscle over skin might be accounted for by the diameter of involved afferents. Muscle afferents are larger (12-21 m) than skin afferents (6 -12 m).
DISCUSSION
15
Intramuscular contraction and immediate relaxation of treated muscle fibers with simultaneous eccentric contraction of the antagonist muscle may relieve pain from stretch effects on the agonists and antagonistic muscle fibers. Stretching of tight muscles is common in clinical rehabilitation to relieve pain, to diminish muscle tension and tenderness, and to enhance range of motion. Muscle stretching exercises are commonly used in sports activities to gain flexibility. 16 Possibly because of muscle stretching effects, treatments that involved muscle, MS and ETOIMS (not SS), immediately improved physical measures. The lack of improvement in other physical measures may be related to the associated residual lower back pain that persisted immediately after treatment.
Despite widespread use, the mechanism behind the effects of stretching remains controversial. A reduction in passive stiffness of the muscle tendon unit may be the mechanism for the beneficial effects of stretching. [17] [18] [19] External muscle stretching, such as focal muscle massage, may be effective in stretching the superficial muscle fibers, but the degree of stretching may not be as much as that of muscle contraction and relaxation. Also, external muscle stretching procedures may not provide adequate stretch to deep muscle fibers that may be focally shortened. Surface electrical stimulation, such as faradic and interferential currents, may exert muscle stretching effects more effectively on shortened superficial muscle fibers than on deep muscle fibers. With surface electrical stimulation, less current reaches deeply situated MEPZs. Placing needle electrodes directly into deeper muscle tissues via ETOIMS enables delivery of electrical stimuli to these fibers.
Muscle contractions improve skin and muscle circulation. Electrical stimulation-induced contractions improve circulation of the lower leg by the physiologic pumping action of muscle, reducing venous stasis/pooling and edema. 20 Immediately after muscle contraction, muscle microvessels exhibit increased convective (flow of red blood cells) and diffusive (perfused capillary surface area) transport. 21 The use of low-frequency transcutaneous nerve stimulation (2 Hz), producing moderate muscle contractions, leads to a transient, local increase in blood flow in muscle and skin.
22-24 A recent report with blood flow measurements in the common femoral artery showed that surface-twitch contractions at 3 Hz increase perfusion in human leg muscles. 25 Therefore, ETOIMS-mediated muscle contractions may produce pain relief through the following mechanisms of action: spinal cord reflex closure of the pain gate, intramuscular exercise, and enhanced tissue perfusion.
Our data suggest that pain relief occurs when needle stimulation involves deep-muscle MEPZs and increases with the number of MEPZs stimulated, as is possible with ETO-IMS. To elicit twitches for MS and ETOIMS, a firm monopolar EMG needle electrode was used instead of a fine, flexible needle, such as that used in acupuncture and intramuscular stimulation. The monopolar electrode, unlike the acupuncture needle, provides the tensile strength necessary to penetrate through tight, superficial muscles, enabling it to reach deeper muscle layers. This noncutting needle is also designed for repeated needle penetration into muscle.
Percutaneous electrical nerve stimulation (PENS) for treatment of low back pain involves the insertion of multiple acupuncture needles (ten or more) into soft tissue or muscle in the lower back to a depth of 20 -40 mm in a dermatomal distribution and the use of current strength of Ͻ25 mA, stimulation frequency of 4 Hz, and pulse width of 0.5 msecs for 30 mins. 26 No muscle contractions are visibly elicited with PENS, but the electrical stimulation provides tapping sensations, possibly indicating minute needle movements. The mechanism of pain relief in PENS is believed to be caused by central neuromodulation from stimulation of sensory nerves at the dermatomal level. 27 We suggest that the PENS effect is primarily related to needle electrical stimulation of deep muscle MEPZs with associated microtwitchinduced tissue mobilization because minute needle movements can elicit insertional activity. The depth of 20 -40 mm stimulated by PENS is similar to that of our MS and ETO-IMS depth of 37 mm.
In our trial, needle insertion with withdrawal after 2 secs was used to keep all three types of treatment uniform. Two seconds of 2-Hz stimulation is the standard electrophysiologic setting for repetitive stimulation of neuromuscular junctions, to fatigue abnormal or susceptible MEPZs, which is the principle used in ETOIMS. This study confirmed that musculoskeletal pain relief can be achieved by MS and ETOIMS, without employing designated acupuncture needles, inserting these needles at classical acupuncture points, twirl- ing and oscillating the inserted needles, or keeping multiple needles stationary for 20 -30 mins, as in classical acupuncture or PENS.
This study also reveals that ETO-IMS management of lower back pain can be satisfactorily produced after a brief period of training. The treating physician can confidently visualize or palpate the intramuscular and intermuscular grooves. In contrast with classical acupuncture, this makes needle placement in MS and ETOIMS objective and, consequently, easily standardized. Sham acupuncture, which involves needle stimulation at nonacupuncture points, has been noted to have some analgesic effects. 5 It is possible that pain reduction by such needle puncture occurs by stimulation of MEPZs. In our trial, the fact that no analgesic effects were obtained from needle stimulation of skin suggests that the mechanism of sham acupuncture pain relief involves needle penetration into and stimulation of muscle. This is further supported by the fact that PENS (in which the needles are inserted to a depth of 20 -40 mm, involving MS) has been noted to be more effective than transcutaneous nerve stimulation. 26 In addition, transcutaneous nerve stimulation therapy, which does not involve MS, is only marginally more effective than placebo treatment. 28, 29 For all treatment conditions, the VAS scores on the day of treatment were lower than the reported weekly scores. As patient pain was usually lower in the morning and because most treatments occurred in the morning, this contributes to this finding. The pretreatment week's pain levels were the average of the twice-daily (morning and evening) VAS recordings and, thus, were higher than the VAS reported on the morning of the treatment. The lower pretreatment pain score for ETOIMS is not a reflection of the effects of the same order of treatment starting always with MS because SS produced more pain for 2 wks after the treatment (Fig. 1) . This helps establish that a 2-wk washout period is sufficient for patients with chronic pain, confirming the clinical experience of the primary author. 10 -12 Potential bias was inadvertently introduced in this study because the treatment was not randomized and because patients could not be adequately blinded to use of the electrical stimulus, despite utilizing an outof-sight, silent switch. Also, electrical stimulation might have a placebo effect for which there was no control.
There were no complications or adverse effects related to this study. The treatment sequence (crossover) was not randomly assigned because a test trial showed that manual insertion of the needle to stimulate skin was very painful, inducing posttreatment pain. To prevent patient dropoff, we kept the protocol sequence of MS, then SS, and then ETOIMS. The same order of treatments was used for all patients, with ETOIMS treatment 4 wks after MS. Therefore, there is the potential that the VAS levels after SS and ETOIMS were affected by MS. However, cumulative effects of MS do not influence the subsequent pain reduction by ETO-IMS because after SS, the pain was noted to increase (Fig 1) . SS may inadvertently apply inadequate stimulus to the underlying muscle fibers, allowing them to shorten and tighten without relaxation, aggravating the pain.
A previous, noncontrolled, clinical study suggested that there is an analgesic effect of ETOIMS in musculoskeletal pain. 12 This study confirmed that ETOIMS and, to a lesser extent, MS are effective in reducing VAS levels in low back pain and that SS is not effective. We also showed that a single treatment with ETOIMS produced qualitatively a higher percentage of pain reduction than MS and SS (Fig. 1) . On the basis of our findings, further controlled study involving a larger patient population, randomly assigned treatments, and longer follow-up is warranted.
